Prostate Screening Current Events | Prostate Screening News | 3
|
| Page
3 of
47 |
924 Results |
|
|
|
Sort By:
Page Views | Date |
U.S. trial shows no early mortality benefit from annual prostate cancer screening
The prostate cancer screening tests that have become an annual ritual for many men don't appear to reduce deaths from the disease among those with a limited life-expectancy, according to early results of a major U.S. study involving 75,000 men. view more (2009-03-19)
New blood test greatly reduces false-positives in prostate cancer screening
A new blood test used in combination with a conventional prostate-specific antigen (PSA) screening sharply increases the accuracy of prostate cancer diagnosis, and could eliminate tens of thousands of unneeded, painful, and costly prostate biopsies annually, according to a study led by researchers at Dana-Farber Cancer Institute. view more (2009-05-29)
Low-risk prostate cancer patients face overtreatment
Many low-risk prostate cancer patients are being overtreated and might fare better if doctors monitored the cancer until treatment was necessary. view more (2006-08-16)
Prostate cancer screening creates new dilemma for men, says professor
Between 70 and 80 per cent of prostate cancer was now being diagnosed at a stage where it may be curable, a press conference at ECCO 11 - The European Cancer Conference in Lisbon heard today (Wednesday, October 23, 2001). "We used to have a situation in which one of every two patients diagnosed with the disease would die. Today only three to... view more... (2001-10-23)
No magic tomato? Study breaks link between lycopene and prostate cancer prevention
Tomatoes might be nutritious and tasty, but don't count on them to prevent prostate cancer. view more (2007-05-17)
Statins may exert influence on prostate cancer growth by reducing inflammation
Cholesterol-lowering drugs called statins may reduce inflammation in prostate tumors, possibly hindering cancer growth, according to a study led by investigators in the Duke Prostate Center. view more (2009-04-27)
SPCG-4 trial: Update on watchful waiting versus radical prostatectomy
In 2005, the Scandinavian Prostate Cancer Group Study 4 (SPCG-4) reported that radical prostatectomy improved prostate cancer survival compared with watchful waiting after a median of 8.2 years of follow-up. view more (2009-03-23)
MR imaging helps predict recurrence in prostate cancer patients
MR images taken of prostate cancer patients prior to treatment that show that the cancer has spread outside the prostate gland capsule help predict whether the cancer will return. view more (2007-05-07)
Surgery reduces mortality in prostate cancer but does not not influence quality of life or overall survival
Two large Scandinavian studies evaluating the long-term effect of prostate cancer treatment are published in The New England Journal of Medicine this week. In the first study, 695 men with newly diagnosed prostate cancer were randomised assigned to radical prostatectomy or watchful waiting. The result shows that radical prostatectomy significantly... view more... (2002-09-11)
University of Kent Study Aims To Improve Information And Support Needs For Older Men With Prostate Cancer
The Centre for Health Services Studies (CHSS) at the University of Kent is currently engaged in an exploratory study of the information and support needs for men aged 75+ with prostate cancer. view more (2004-11-03)
Family history of prostate cancer does not affect some treatment outcomes
In a first of its kind study, a first-degree family history of prostate cancer has no impact on the treatment outcomes of prostate cancer patients treated with brachytherapy (also called seed implants), and patients with this type of family history have clinical and pathologic characteristics similar to men with no family history at all, according... view more... (2009-01-05)
UroGene and Pierre Fabre Médicament sign letter of intent
UroGene S.A. (Evry Génopole - France) and Pierre Fabre Médicament announced today the signature of a letter of intent for a three year collaboration to discover and develop new active compounds against a biological target identified by UroGene in advanced prostate cancer. This target is a cell surface protein which is elevated in... view more... (2002-01-28)
PSA test has higher accuracy for patients taking finasteride
Finasteride is a drug prescribed for men whose prostates have become enlarged. The drug decreases prostate swelling and helps men with urinary problems. view more (2006-08-16)
Prostate Cancer Survival Benefit From A Combination Of Androgen Suppression And External Irradiation
Disease-free survival from advanced prostate cancer could be almost doubled if hormone-suppression therapy is used during and after radiotherapy for a duration of 3 years, suggest authors of an international study in this week's issue of THE LANCET. Long-term survival after radiotherapy for people with advanced prostate cancer is poor. Michel... view more... (2002-07-05)
3T MRI plays significant role in detecting prostate cancer, study says
The use of MRI without endorectal coil can detect prostate cancer and provide undistorted images with diagnostic image quality and accurate tumor localization, according to a recent study conducted by researchers from The Ohio State University in Columbus, OH. view more (2008-04-14)
Sensitive and specific biomarker for early detection of prostate cancer identified
Scientists at a Maryland-based pharmaceutical company have preliminary evidence showing that a protein in the blood may prove to be a biomarker that is more sensitive and specific than current methods of early detection for prostate cancer. view more (2006-09-14)
Prostate cancer spurs new nerves
Prostate cancer - and perhaps other cancers - promotes the growth of new nerves and the branching axons that carry their messages, a finding associated with more aggressive tumors, said researchers from Baylor College of Medicine in the first report of the phenomenon that appears today in the journal Clinical Cancer Research. view more (2008-12-01)
Study finds acceptable levels of anxiety among men living with early, untreated prostate cancer
Men with early stages of prostate cancer who delay radical treatment in favor of an approach of "expectant management" do not have high levels of anxiety and distress. view more (2009-07-27)
Jefferson scientists find protein potential drug target for treatment-resistant prostate cancer
Scientists at Jefferson's Kimmel Cancer Center in Philadelphia have found that a signaling protein that is key to prostate cancer cell growth is turned on in nearly all recurrent prostate cancers that are resistant to hormone therapy. view more (2008-01-02)
New prostate cancer marker helps identify men whose cancer is likely to spread
Prostate cancer researchers at Sydney's Garvan Institute, supported by the Cancer Institute NSW, have found a new marker for identifying aggressive prostate cancers. view more (2006-10-04)
|
|
| Page
3 of
47 |
924 Results |
|
|
|
Sort By:
Page Views | Date |
|
